Founded in 2004 and headquartered in Maryland, eEnzyme LLC develops research reagents, cell-based assay tools, and custom scientific solutions for life science laboratories worldwide. Its work is especially distinctive for combining infectious-disease research tools with ACTOne™ receptor cell lines, replication-deficient pseudovirus systems, and custom GPCR/PDE studies. eEnzyme supports academic, biotechnology, pharmaceutical, and government researchers from its Maryland operations.